Could Human Cloning Ever Be Used in Medicine?
A careful look at the medical claims sometimes attached to cloning research — and what serious researchers are actually doing instead.
When people imagine medical uses of cloning, the scenarios usually fall into one of two categories: cloning a person to replace a lost loved one, or cloning a person to produce spare parts. Neither maps onto what serious medical research is actually pursuing, and neither is treated as acceptable in current biomedical ethics.
What is not being pursued
- Cloning to replace a person. Reproductive cloning of humans is broadly prohibited. It is also conceptually mistaken: a clone is not a copy of a person’s mind, history, or relationships. The strongest ethical literature against this idea is independent of safety concerns.
- “Spare parts” cloning. The idea of producing a person to harvest tissues or organs is condemned in essentially every modern bioethics framework and has no support in the peer-reviewed clinical literature. This site rejects the framing.
What is being pursued
The realistic medical conversation about cloning is much less dramatic. It revolves around the use of cells, not people, and overlaps almost entirely with stem-cell research:
- Disease modelling. Pluripotent stem cells derived from patients can be turned into cell types affected by a particular disease, giving researchers a model to study the biology in a dish.
- Drug screening. Cell-based models can be used to test candidate treatments under controlled conditions.
- Cell-replacement research. Long-running studies investigate whether cells derived from pluripotent sources could one day repair damaged retinas, pancreatic islets, or neurons. This remains research, not standard treatment.
Most of this work uses induced pluripotent stem cells (iPSCs) rather than therapeutic cloning. iPSCs were a separate breakthrough in 2006–2007 that does not require an embryo.
Where therapeutic cloning still fits
Therapeutic cloning — using somatic cell nuclear transfer to derive donor-matched pluripotent cells — still has a research role, particularly in studies that compare reprogrammed cells across methods. It is heavily regulated where it is permitted at all, and it is no longer the dominant route to donor-specific pluripotent cells.
What we should be cautious of
A few claims about cloning and medicine tend to circulate without much basis:
- “Cloning will let people live forever.” Cloning does not duplicate a mind. The biological clock of the resulting cells is also not the same as the biological clock of the donor.
- “Genetic preservation services” that imply future cloning. Such marketing exists. The current regulatory environment in most jurisdictions makes reproductive cloning of people prohibited. This site does not endorse any such service.
- “Personalised cloning therapy” as a near-term consumer offering. Standard-of-care medicine does not include cloning-derived therapies; what does exist is carefully regulated research.
Editorial note
HumanCloning.org does not promote any service that claims to offer cloning-derived treatments, genetic preservation for cloning purposes, or cell-based therapies outside formally approved clinical channels.
Where the field is actually heading
The realistic medical future of cloning-adjacent research is more modest than the headlines suggest, but also more interesting:
- Better disease models built from patient-derived pluripotent cells.
- Cell-replacement strategies for a small number of conditions where the science is mature enough.
- Deeper understanding of how cells acquire and lose identity, with applications across regenerative medicine.
Key takeaway
Cloning in the popular sense is not a medical agenda. The serious medical work that uses cloning-related techniques is overwhelmingly about cells, regulated carefully, and increasingly displaced by other reprogramming methods.